Skip to main content
OpenTrials
Completed

NCT Number: NCT06660979

Using Reinforcement Learning to Personalize Electronic Health Record Tools to Facilitate Deprescribing

The overall goal of the proposed research is to refine and adapt and perform efficacy testing of a novel reinforcement learning-based approach to personalizing EHR-based tools for PCPs on deprescribing of high-risk medications for older adults. The trial will be conducted at Atrius Health, an integrated delivery network in Massachusetts, and will intervene upon primary care providers. The investigators will conduct a cluster randomized trial using reinforcement learning to adapt electronic health record (EHR) tools for deprescribing high-risk medications versus usual care. 70 PCPs will be randomized (i.e., 35 each to the reinforcement learning intervention and usual care [no EHR tool] in each arm) to the trial and follow them for approximately 30 weeks. The primary outcome will be discontinuation or ordering a dose taper for the high-risk medications for eligible patients by included primary care providers, using EHR data at Atrius. The primary hypothesis is that the personalized intervention using reinforcement learning will improve deprescribing compared with usual care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Atrius Health

Boston, Massachusetts, 02215, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The trial will intervene upon primary care providers (including physicians and PCP-designated nurse practitioners and physician assistants) at Atrius Health.

Patients of the PCPs will be included in the intervention and analysis if they are >/=65 years of age and have been prescribed >/= 90 pills of high-risk medications in the prior 180 days based on EHR data.

Exclusion criteria

  • Not a primary care provider at Atrius Health

Treatment and study plan

Reinforcement Learning

Behavioral

The intervention is a reinforcement learning program that personalizes EHR-based tools for PCPs to promote deprescribing high-risk medications over follow-up. The reinforcement learning intervention selects a tool for each provider based on an algorithm from an inventory of EHR tools and chooses tools that are predicted to motivate action for the individual provider. The inventory of EHR tools from which the algorithm will choose include the following potential factors: open encounter, order entry, cold-state outreach, simplification, and risk framing.

Primary outcomes

  1. Discontinuation or taper for high-risk medication

    Time frame: Through trial completion, up to 7 months

    Deprescribing will be assessed using routinely collected data from the EHR system for eligible patients flagged as in need of deprescribing. The deprescribing outcome will be a "reduction" in inappropriate prescribing, defined as either discontinuation of one the the medication classes of interest or ordering a dose taper.

Secondary outcomes

  1. Discontinuation of high-risk medication

    Time frame: Through trial completion, up to 7 months

    Discontinuation of medication assessed using routinely-collected data from the EHR system for eligible patients flagged as in need of deprescribing.

Sponsors and collaborators

Lead sponsor

Brigham and Women's Hospital

Other

Collaborators

  • Atrius Health
  • National Institute on Aging (NIA)

Registry information

Acronym: REINFORCE-EHR

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Oct 28, 2024
Registry last updated
Apr 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.